Practical Considerations for Recognizing, Diagnosing, and Managing Non-Cystic Fibrosis Bronchiectasis: A Care Team Forum®

Program Overview

The goal of this activity is to raise awareness of and educate on the diagnostic testing and multifaceted management essential for patients with NCFBE. Clinicians will learn about the important role of neutrophil serine proteases (NSPs) in NCFBE pathophysiology, including emerging therapies that target neutrophilic inflammation. An experienced patient with NCFBE shares her difficult diagnostic and therapeutic journey and provides impactful insights for clinical care.

Credit Expired

Target Audience

This activity is intended for pulmonary, infectious diseases, radiology, and primary care clinicians who manage patients with non-cystic fibrosis bronchiectasis (NCFBE).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Apply current criteria for diagnosing non-cystic fibrosis bronchiectasis (NCFBE)
  • Employ current management strategies for the treatment of patients with NCFBE
  • Examine the role of neutrophil serine proteases (NSPs) in the pathophysiology of NCFBE
  • Assess the potential impact of emerging therapies targeting NSPs on the treatment of NCFBE

Activity Faculty


Doreen J. Addrizzo-Harris, MD (Chair)

Professor, Medicine
Associate Director, Clinical and Academic Affairs
Director, NYU Bronchiectasis/NTM Program
NYU Grossman School of Medicine
New York, NY

Daley_Charles - 300px

Charles L. Daley, MD

Chief, Division of Mycobacterial & Respiratory Infections
Professor, Medicine
National Jewish Health
Denver, CO


Anne E. O’Donnell, MD

Professor, Medicine
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Georgetown University Medical Center
Washington, DC


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources